Search
Now showing items 1-10 of 15
Article
WIN 55,212-2 shows anti-inflammatory and survival properties in human iPSC-derived cardiomyocytes infected with SARS-CoV-2
| Date Issued:
2021 | Copyright:
open access
Article
Unlike Chloroquine, Mefloquine Inhibits SARS-CoV-2 Infection in Physiologically Relevant Cells
| Date Issued:
2022 | Copyright:
open access
Article
Commercially Available Flavonols Are Better SARS-CoV-2 Inhibitors than Isoflavone and Flavones
| Date Issued:
2022 | Copyright:
open access
Article
Combination of antiviral drugs inhibits SARS-CoV- 2 polymerase and exonuclease and demonstrates COVID-19 therapeutic potential in viral cell culture
| Date Issued:
2022 | Copyright:
open access
Article
SARS-CoV-2 Proteins Bind to Hemoglobin and Its Metabolites
| Date Issued:
2021 | Copyright:
open access
Article
VIP plasma levels associate with survival in severe COVID-19 patients, correlatingwith protective effects in SARS-CoV-2-infected cells
| Date Issued:
2022 | Copyright:
open access
Article
Human endogenous retrovirus K in the respiratory tract is associated with COVID‑19 physiopathology
| Date Issued:
2022 | Copyright:
open access
Article
In vitro antiviral activity of the anti-HCV drugs daclatasvir and sofosbuvir against SARS-CoV-2, the aetiological agent of COVID-19
| Date Issued:
2021 | Copyright:
open access
Article
Atazanavir Is a Competitive Inhibitor of SARS-CoV-2Mpro, Impairing Variants Replication In Vitro and In Vivo
| Date Issued:
2022 | Copyright:
open access
Article
Agathisflavone, a natural biflavonoid that inhibits SARS-CoV-2 replication by targeting its proteases
| Date Issued:
2022 | Copyright:
open access